Loading Events

« All Events

  • This event has passed.

Adaptive Designs in Clinical Development

November 9, 2016 @ 8:00 am - 10:00 am

We will explore these important questions and more including:

  • Are sponsor companies using adaptive designs in Phase 1 and 2 studies more than before? Perhaps even more so than in Phase 3 confirmatory trials?
  • Why are adaptive designs appropriate in early phase trials and present case studies?
  • How can drug development programs optimize efficiency using these designs earlier than Phase 3?

Come join the conversation, bring your questions and share your own experiences.


  • Deepak L. Bhatt, MD, MPH, Executive Director of Interventional Cardiovascular Programs, Brigham & Women’s Hospital, Professor, Harvard Medical School
  • Mark Chang, PhD, Senior Vice President, Veristat LLC
  • Yi Liu, PhD, Senior Manager, Takeda Pharmaceuticals International Co.
  • Cyrus Mehta, PhD, President, Cytel
  • Stella Sergiopolous, MS, MPH, Research Fellow, Tufts Center for the Study of Drug Development


  • John Balser, PhD, Co-founder and President, Veristat LLC

Please register here.


MassBio 8th Floor
300 Technology Square
Cambridge, MA 02139 United States
+ Google Map